Basiliximab is available by prescription and is given to help prevent a kidney transplant rejection. It comes as a powder that is dissolved in fluid and administered as an intravenous (IV) injection or infusion by a healthcare provider. Although this can be an effective medicine, it may not be suitable for some people who are taking certain medications or who have certain medical conditions.
What Is Basiliximab?
Basiliximab (Simulect®) is a prescription medication approved to prevent the body from rejecting a newly transplanted kidney. It is used in combination with other anti-rejection medications, including cyclosporine (Gengraf®, Neoral®, Sandimmune®) and a corticosteroid.
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Simulect [package insert]. East Hanover, NJ: Novartis Pharmaceuticals Corporation;2005 September.
Food and Drug Administration Web site. Vaccines, Blood and Biologics, Resources for Healthcare Providers. Available at: http://www.fda.gov/BiologicsBloodVaccines/ResourcesforYou/HealthcareProviders/default.htm. Accessed September 30, 2011.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 8th ed. Philadelphia (PA): Lippincott Williams & Wilkins;2008.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click